tobramycin has been researched along with nystatin a1 in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
| Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
| Bender, JF; Brouillet, MD; Fortner, CL; Love, LJ; Schimpff, SC; Wiernik, PH; Young, VM | 1 |
| Barois, A; Bourda, JL; Chapuis, C; Combes, A; Goulon, M; Grosbuis, S; Simon, N | 1 |
| Boyer, G; Darbas, H; Donadio, D; Monnet, P; Ramounau-Pigot, A | 1 |
| Ashida, T; Hasegawa, H; Horiuchi, A; Irimajiri, K; Iwanaga, T; Tsubaki, K | 1 |
| del Rey-Calero, J; García Gonzalez, JI; García-Magan, P; Herruzo-Cabrera, R | 1 |
| Andreoni, B; Biffi, R; Gatti, S; Marini, A; Marzona, L; Matinato, C; Nicastro, G; Piazzini, A; Privitera, G; Rossi, G | 1 |
| Hove, H; Mortensen, PB; Tvede, M | 1 |
| Andreoni, B; Biffi, R; Conte, E; Gatti, S; Privitera, G; Rossi, G | 1 |
| Hansen, BA; Heslet, L; Hjortrup, A; Høiby, N; Kirkegaard, P; Moesgaard, F; Rasmussen, A | 1 |
| Alvarado, F; Delgado, MA; Dorao, P; García, S; Goded, F; Herruzo, R; Ruza, F | 1 |
| Cuthbertson, BH; Daneman, N; Fowler, RA; Sarwar, S | 1 |
1 review(s) available for tobramycin and nystatin a1
| Article | Year |
|---|---|
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clinical Trials as Topic; Cross Infection; Decontamination; Digestive System; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacteriaceae; Europe; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Neomycin; Nystatin; Odds Ratio; Oropharynx; Polymyxins; Prevalence; Primary Prevention; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; South Africa; Tobramycin; United States; Vancomycin | 2013 |
3 trial(s) available for tobramycin and nystatin a1
| Article | Year |
|---|---|
A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Intestines; Leukemia; Nystatin; Tobramycin; Vancomycin | 1979 |
[Prevention of septicemia caused by gastrointestinal tract organisms in patients with granulopenia. Comparison of three gastrointestinal tract decontamination treatments].
Topics: Agranulocytosis; Colistin; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Nystatin; Sepsis; Tobramycin; Vancomycin | 1991 |
Prevention of nosocomial infection in a pediatric intensive care unit (PICU) through the use of selective digestive decontamination.
Topics: Adolescent; Antibiotic Prophylaxis; Child; Child, Preschool; Colistin; Cross Infection; Digestive System; Drug Therapy, Combination; Female; Hexetidine; Humans; Infant; Intensive Care Units, Pediatric; Male; Multiple Organ Failure; Multivariate Analysis; Nystatin; Prospective Studies; Regression Analysis; Respiratory Tract Infections; Severity of Illness Index; Tobramycin; Urinary Tract Infections | 1998 |
12 other study(ies) available for tobramycin and nystatin a1
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Treatment of mediastinitis in children after cardiac surgery. A study of 20 cases.
Topics: Child; Child, Preschool; Gentamicins; Heart Defects, Congenital; Humans; Infant; Infusions, Parenteral; Mediastinitis; Nystatin; Prognosis; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tobramycin; Vancomycin | 1978 |
[Prophylactic nonabsorbable antibioticsin the increasing incidence of infection in patients with hematological diseases].
Topics: Acute Disease; Administration, Oral; Anemia, Aplastic; Bacterial Infections; Bone Marrow Transplantation; Drug Therapy, Combination; Humans; Intestines; Leukemia; Nystatin; Premedication; Tobramycin; Vancomycin | 1985 |
Nosocomial infection in a neonatal intensive care unit and its prevention with selective intestinal decolonization. A multivariant evaluation of infection reduction.
Topics: Chi-Square Distribution; Cohort Studies; Colistin; Confounding Factors, Epidemiologic; Cross Infection; Drug Therapy, Combination; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Intestines; Logistic Models; Multivariate Analysis; Nystatin; Prospective Studies; Spain; Tobramycin | 1994 |
Enteric bacterial overgrowth and translocation in a swine model of small bowel transplantation.
Topics: Animals; Bacteria, Aerobic; Bacterial Infections; Colistin; Drug Therapy, Combination; Enterobacteriaceae; Female; Intestine, Small; Liver; Liver Transplantation; Lung; Lymph Nodes; Mycoses; Nystatin; Postoperative Complications; Spleen; Swine; Tobramycin; Transplantation, Autologous; Vancomycin | 1994 |
Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clostridioides difficile; Colon; Diarrhea; Fatty Acids, Volatile; Female; Humans; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Nystatin; Tobramycin | 1996 |
Influence of different protocols of antibiotic prophylaxis on endoluminal bacterial overgrowth and translocation following small-bowel or combined liver-small-bowel transplantation in a large-animal model.
Topics: Animals; Antibiotic Prophylaxis; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefazolin; Colistin; Cyclosporine; Drug Therapy, Combination; Enterobacteriaceae; Female; Intestine, Small; Liver; Liver Transplantation; Lung; Lymph Nodes; Nystatin; Spleen; Swine; Tobramycin; Transplantation, Homologous; Vancomycin | 1997 |
Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination.
Topics: Adolescent; Adult; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Feces; Graft Rejection; Humans; Infant; Liver Transplantation; Middle Aged; Mycoses; Nystatin; Postoperative Complications; Regression Analysis; Retrospective Studies; Risk Factors; Tobramycin | 1997 |